Elequin Capital’s Innoviva INVA Stock Holding History

Elequin Capital’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$818	Buy	36 +9	+33%	+$206	﹤0.01%	585
2026 Q1	$629	Sell	27 -40	-60%	-$862	﹤0.01%	567
2025 Q4	$1.34K	Buy	+67	New	+$1.31K	﹤0.01%	368
2025 Q3	–	Sell	-25	Closed	-$502	–	259
2025 Q2	$502	Buy	+25	New	+$481	﹤0.01%	351
2025 Q1	–	Sell	-4	Closed	-$69	–	474
2024 Q4	$69	Sell	4 -465	-99%	-$8.93K	﹤0.01%	495
2024 Q3	$9.06K	Buy	+469	New	+$8.64K	﹤0.01%	250
2024 Q2	–	Sell	-311	Closed	-$4.74K	–	266
2024 Q1	$4.74K	Buy	311 +297	+2,121%	+$4.67K	﹤0.01%	156
2023 Q4	$225	Sell	14 -6	-30%	-$84	﹤0.01%	332
2023 Q3	$260	Sell	20 -420	-95%	-$5.45K	﹤0.01%	360
2023 Q2	$5.6K	Buy	+440	New	+$5.51K	﹤0.01%	358

Other funds holding INVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Elequin Capital's INVA Position: Q2 2026 in Review

Elequin Capital increased its Innoviva (INVA) stake by 33% in Q2 2026, buying an estimated $206 and bringing the position to 36 shares worth $818. The position accounts for ﹤0.01% of the portfolio, ranked #585.

Elequin Capital first reported a position in INVA in Q2 2023 and has held it in 10 quarters since. The position peaked at $9.06K in Q3 2024. 309 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

Elequin Capital held 36 shares of Innoviva worth $818 as of Q2 2026.
Elequin Capital bought 9 Innoviva shares in Q2 2026, an estimated $206.
Innoviva made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #585 holding.
Elequin Capital first reported a position in Innoviva in Q2 2023 and has held it in 10 quarters since.
Elequin Capital's Innoviva position peaked at $9.06K in Q3 2024.
309 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.